70 results
8-K
EX-10.1
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
accountants as required by the Securities Act and the Exchange Act and the regulations thereunder and the Public Company Accounting Oversight Board.
4.5 … for the oversight of such preclinical tests and studies or clinical trials. The descriptions of the Studies contained in the SEC Documents are accurate
8-K/A
EX-99.2
bva0s9vcf whvp
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.3
pf8xnutxhjjpe h16
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
zuzzrrzqwe1 vtmrlpd8
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
kwfi26fuy8lj
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
bxmv7yugskkt
10 May 23
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.29
13eua nkztev7pfx2
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
3397w6ttxo 7f41li
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
hy5ett
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
PRRN14A
yvymxya1 zton
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFC14A
jl62r28
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
miinb
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PRER14A
5ojir6917xwo 5z
28 Nov 22
Preliminary revised proxy
5:17pm